Zacks Investment Research
12 Jun 2026, 10:45 UTC · 15w ago
Verdict
Headline takes no side. We score ADPT +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Adaptive Biotechnologies (ADPT) shares rose 9.7% in the last trading session on high volume, following a 30% gain over the past four weeks.
More positive than 79% of claims this week
Analysts have revised the consensus EPS estimate for Adaptive Biotechnologies (ADPT) 3.6% higher over the last 30 days.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 66% of claims this week
Adaptive Biotechnologies is expected to report a quarterly revenue increase of 14.2% year-over-year to $67.24 million in its next report.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
Shares rallied 9.7% following robust financial results and growing investor confidence in its lead product and pipeline.
More positive than 57% of ticker scores this week
The stock finished the last trading session 4.4% higher, although it has declined over the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
1h ago
+52.2%
Price agrees with the score
$28.51 vs $18.73 close before publication (Jun 11) · not market-adjusted
ADPT chart →
